(Q36223799)

12 August 2017

1 reference

title

Management of occupational and nonoccupational postexposure HIV prophylaxis (English)

1 reference

12 August 2017

Mitchell H Katz

1

1 reference

12 August 2017

Julie Louise Gerberding

series ordinal

2

1 reference

12 August 2017

publication date

1 December 2004

1 reference

12 August 2017

published in

Current HIV/AIDS reports

1 reference

12 August 2017

volume

1

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

159-165

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-004-0025-8

12 August 2017

exact match

0 references

cites work

Prophylaxis for occupational exposure to HIV.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0025-8

Per-contact risk of human immunodeficiency virus transmission between male sexual partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0025-8

The care of persons with recent sexual exposure to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0025-8

Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0025-8

Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-004-0025-8

HIV postexposure prophylaxis for children and adolescents

21 January 2018

1 reference

12 December 2020

Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians' experiences and attitudes

1 reference

12 December 2020

Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group

1 reference

12 December 2020

Should preventive antiretroviral treatment be offered following sexual exposure to HIV? The case for.

1 reference

12 December 2020

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

1 reference

12 December 2020

Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen

1 reference

12 December 2020

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

1 reference

12 December 2020

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

1 reference

12 December 2020

Should preventive antiretroviral treatment be offered following sexual exposure to HIV? Not yet!

1 reference

12 December 2020

Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections

1 reference

12 December 2020

Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus

1 reference

12 December 2020

Tolerability and side-effects of post-exposure prophylaxis for HIV infection

1 reference

12 December 2020

Zidovudine toxicity in uninfected healthcare workers

1 reference

12 December 2020

Clinical practice. Occupational exposure to HIV in health care settings

1 reference

12 December 2020

Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.

1 reference

12 December 2020

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

1 reference

12 December 2020

Post-exposure prophylaxis (PEP) after non-occupational risk of HIV infection.

1 reference

12 December 2020

Failures of zidovudine postexposure prophylaxis

1 reference

12 December 2020

Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations

1 reference

12 December 2020

Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.

1 reference

12 December 2020

Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.

1 reference

12 December 2020

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

12 December 2020

Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service

1 reference

12 December 2020

A model-based estimate of HIV infectivity via needle sharing

1 reference

12 December 2020

Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus

1 reference

12 December 2020

Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault

1 reference

12 December 2020

The estimated prevalence and incidence of HIV in 96 large US metropolitan areas

1 reference

12 December 2020

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

1 reference

12 December 2020

Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.

1 reference

12 December 2020

Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

Approval of a new rapid test for HIV antibody

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study

1 reference

12 December 2020

Needlestick transmission of hepatitis C.

1 reference

12 December 2020

Infectiousness of HIV between male homosexual partners

1 reference

12 December 2020

Sexual transmission of HIV.

1 reference

12 December 2020

Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV

1 reference

12 December 2020

Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse.

1 reference

12 December 2020

The role of psychosocial assessment and support in occupational exposure management

1 reference

12 December 2020

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis

1 reference

12 December 2020

10.1007/S11904-004-0025-8

Identifiers

DOI

1 reference

12 August 2017

1 reference